This image is not available for purchase in your country.

Bexsero, meningitis B vaccine

Bexsero, meningitis B vaccine

C026/3253

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions:

Editorial use only.

Caption

Bexsero, meningitis B vaccine. Pre-filled syringes of Bexsero, the meningococcal vaccine used against meningitis B, a disease caused by serogroup B of the Neisseria meningitidis bacterium. Meningitis is a potentially fatal inflammation of the brain membranes (meninges). This vaccine was developed by Novartis and approved for use in the European Union in January 2013. It was added to the UK childhood immunisation programme from 1 September 2015.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}